APPLICABILITY OF THE NANO-DRUG DELIVERY SYSTEM FOR THE DEALING OF CARDIOVASCULAR DISEASES: A REVIEW PAPER

Abstract

In human life and wellbeing, cardiovascular diseases (CVDs) have become a significant threat. Although many drugs that act through different mechanisms of action are available on the market as conventional CVD treatment formulations, due to poor water solubility, low biological efficacy, non-targeting, and drug resistance, they are still far from satisfactory. With the advancement of nanotechnology, nano-drug delivery systems (NDDSs) provide a modern drug delivery approach for the treatment of CVDs, showing great advantages in solving the above issues. Nevertheless, there are several questions that need to be discussed about NDDSs, such as cytotoxicity. The types and targeting methods of NDDSs have been summarized in this study and the latest research advancement in the diagnosis and treatment of CVDs has been reviewed in recent years. In order to provide more ideas for the improvement of cardiovascular drugs, future prospects for nano-carriers in drug delivery for CVDs include gene therapy.